Abnormal MRI findings of the orbital or visual pathways in patients with severe COVID-19: Observations from the French multicenter COVID-19 cohort.


Journal

Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 17 05 2021
revised: 05 07 2021
accepted: 07 07 2021
pubmed: 21 7 2021
medline: 26 11 2021
entrez: 20 7 2021
Statut: ppublish

Résumé

COVID-19 is a multisystemic disease. Ophthalmological abnormalities are relatively rare among COVID-19-infected patients. The aim of our study was to report orbital and visual pathways MRI findings in a nationwide multicenter cohort of patients with severe COVID-19. This IRB-approved retrospective multi-center study included participants presenting with severe COVID-19, who underwent brain MRI from March 4th to May 1st 2020. Two neuroradiologists ("blinded"), blinded to all data, individually analyzed morphological MRIs focusing on the orbits and the visual pathways. A second consensus reading session was performed in the case of disagreement between both readers. Clinical and ophthalmological data were compared to MRI findings. Descriptive statistical analysis and interobserver agreement for MRI reading using non-weighted Cohen kappa statistics were performed. 129 participants (43 [33%] women and 86 [67%] men, mean age 63 ± 14 years) were included in the study. 17/129 (13%) patients had abnormal MRI findings of the orbit or visual pathways. 11/17 (65%) patients had a FLAIR-WI hyperintense optic disc. 6/17 (35%) patients had abnormal signal of at least one of the visual pathway structures: 6/6 (100%) of the optic nerve, 1/6 (17%) of the optic chiasm, 2/6 (33%) of the optic tract and 1/6 (17%) of the optic radiations. Our study showed that a substantial number of patients with severe COVID-19 presented with abnormal MRI findings of the orbit or visual pathways, which might lead to potentially severe visual impairment.

Identifiants

pubmed: 34284038
pii: S0150-9861(21)00137-1
doi: 10.1016/j.neurad.2021.07.004
pmc: PMC8285938
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-336

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Références

J Neuroradiol. 2021 Mar;48(2):121-124
pubmed: 32437707
Orbit. 2020 Aug;39(4):305-310
pubmed: 32419568
Radiology. 2021 May;299(2):E226-E229
pubmed: 33591889
Cureus. 2020 Sep 30;12(9):e10726
pubmed: 33145132
J Med Virol. 2020 Sep;92(9):1413-1414
pubmed: 32330304
Ocul Immunol Inflamm. 2020 Jul 3;28(5):739-744
pubmed: 32569494
Nat Commun. 2020 Sep 2;11(1):4400
pubmed: 32879306
Lancet. 2020 Feb 22;395(10224):e39
pubmed: 32035510
Taiwan J Ophthalmol. 2020 Sep 16;10(3):153-166
pubmed: 33110745
Ocul Immunol Inflamm. 2020 Apr 2;28(3):391-395
pubmed: 32175797
Radiology. 2020 Dec;297(3):E313-E323
pubmed: 32677875
Ocul Immunol Inflamm. 2020 Aug 17;28(6):916-921
pubmed: 32870738
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620976018
pubmed: 33238757
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Mult Scler Relat Disord. 2020 Nov;46:102474
pubmed: 32892062
Neurology. 2020 Sep 29;95(13):e1868-e1882
pubmed: 32680942
AJR Am J Roentgenol. 2021 Oct;217(4):959-974
pubmed: 33236647
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
J Immunol. 1993 Sep 15;151(6):3381-9
pubmed: 8397257
Mult Scler Relat Disord. 2020 Oct;45:102377
pubmed: 32698095
Radiology. 2020 Nov;297(2):E242-E251
pubmed: 32544034
Acta Ophthalmol. 2020 Dec;98(8):e951-e959
pubmed: 32421258
Ophthalmology. 2020 Jul;127(7):990
pubmed: 32434673
J Neuroophthalmol. 2020 Sep;40(3):398-402
pubmed: 32604245
JAMA Ophthalmol. 2020 May 01;138(5):575-578
pubmed: 32232433
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
BMJ Open Ophthalmol. 2020 Nov 2;5(1):e000630
pubmed: 33195813
Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1351-1352
pubmed: 32328758

Auteurs

Augustin Lecler (A)

Department of Neuroradiology, Rothschild Foundation Hospital, Paris, France; University of Paris, France. Electronic address: alecler@for.paris.

François Cotton (F)

University of Paris, France.

Francois Lersy (F)

Department of Neuroradiology, CHU Lyon, Lyon, France.

Stéphane Kremer (S)

Department of Neuroradiology, CHU Lyon, Lyon, France.

Françoise Héran (F)

Department of Neuroradiology, Rothschild Foundation Hospital, Paris, France; Department of Neuroradiology, CHU Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH